GlaxoSmithKline PLC Transfer of Shares out of Treasury (4368Z)
15 December 2017 - 6:00PM
UK Regulatory
TIDMGSK
RNS Number : 4368Z
GlaxoSmithKline PLC
15 December 2017
Transfer of Treasury Shares
GlaxoSmithKline plc
(the 'Company')
Notification of Transfer of Shares out of Treasury
On 14 December 2017, the Company transferred 38,600,000 ordinary
shares of 25 pence each ("Ordinary Shares") that were held by the
Company in treasury ("Treasury Shares") to BNY Mellon, the
depositary of the Company's American depositary receipts ("ADR")
programme, to procure the issuance and transfer of 19,300,000 ADRs
of the Company to the GlaxoSmithKline (US) Trust (the "Trust") to
be used to satisfy awards granted under the Company's Deferred
Annual Bonus Plan, Performance Share Plan and Share Value Plan. The
consideration received from the trustee for the Company procuring
the issuance and transfer of the ADRs to the Trust was $35.58 per
ADR, representing $17.79 per Ordinary Share, which was funded by a
contribution to the Trust from GlaxoSmithKline LLC.
Following the transfer, the Company's issued share capital
consisted of 5,372,504,800 Ordinary Shares, of which 414,605,950
were held as Treasury Shares.
Therefore, the total number of voting rights in the Company is
4,957,898,850. This figure may be used by shareholders as the
denominator for the calculations by which they will determine if
they are required to notify their interest in, or a change to their
interest in, the Company under the Financial Conduct Authority's
Disclosure Guidance and Transparency Rules.
V A Whyte
Company Secretary
15 December 2017
This information is provided by RNS
The company news service from the London Stock Exchange
END
TRSFFLEELFWSEEE
(END) Dow Jones Newswires
December 15, 2017 02:00 ET (07:00 GMT)
Gsk (LSE:GSK)
Historical Stock Chart
From Apr 2024 to May 2024
Gsk (LSE:GSK)
Historical Stock Chart
From May 2023 to May 2024